Elsevier

Life Sciences

Volume 40, Issue 15, 13 April 1987, Pages 1487-1497
Life Sciences

Dopamine receptor subtype imbalance in schizophrenia

https://doi.org/10.1016/0024-3205(87)90381-XGet rights and content

Abstract

We have investigated the radioligand binding properties of D1 and D2 dopamine receptors in postmortem brains from schizophrenic patients. Consistent with previous reports, the schizophrenic population demonstrated a significant 56% increase in D2 dopamine receptor density. Importantly, the D1 dopamine receptor density was significantly reduced by 43%. These alterations in dopamine receptor densities resulted in a highly significant difference in the ratio of D2/D1 dopamine receptors between schizophrenic patients and controls. A correlation between D1 dopamine receptor density and age was apparent in the schizophrenic patients: D1 dopamine receptor density decreased markedly with age and the linear regressions of D1 dopamine receptor density versus age in both the controls and schizophrenic patients had similar slopes. These results may have clinical implications for the treatment of schizophrenia and tardive dyskinesia.

References (56)

  • J.C. Stoof et al.

    Life Sci.

    (1984)
  • P.E. Setler et al.

    Eur. J. Pharmacol.

    (1978)
  • H. Rosengarten et al.

    Life Sci.

    (1983)
  • A.V. Christensen et al.

    Life Sci.

    (1984)
  • A.G. Molloy et al.

    Eur. J. Pharmacol.

    (1985)
  • A.G. Molloy et al.

    Eur. J. Pharmacol.

    (1985)
  • E. Meller et al.

    Life Sci.

    (1985)
  • P. Barone et al.

    Eur. J. Pharmacol.

    (1986)
  • G.R. Breese et al.

    Eur. J. Pharmacol.

    (1985)
  • W. Billard et al.

    Life Sci.

    (1984)
  • E.J. Hess et al.

    Eur. J. Pharmacol.

    (1986)
  • M.W. Hamblin et al.

    Biochem. Pharmacol.

    (1984)
  • P.J. Munson et al.

    Anal. Biochem.

    (1980)
  • F. Owen et al.

    Lancet

    (1978)
  • J.E. Kleinman et al.

    Biological Markers in Psychiatry and Neurology

  • A.V.P. Mackay et al.

    Lancet

    (1980)
  • K. Murugaiah et al.

    Neuropharmacol.

    (1984)
  • R.G. Mackenzie et al.

    Eur. J. Pharmacol.

    (1985)
  • M.L. Porceddu et al.

    Eur. J. Pharmacol.

    (1985)
  • I. Creese et al.

    Eur. J. Pharmacol.

    (1985)
  • C. Pimoule et al.

    Eur. J. Pharmacol.

    (1985)
  • S. Fleminger et al.

    Biochem. Pharmacol.

    (1983)
  • J.T. Coyle et al.

    Neuroleptics: Neurochemical, Behavioral, and Clinical Perspectives

    (1983)
  • I. Creese et al.

    Ann. Rev. Neurosci.

    (1983)
  • I. Creese et al.

    Science

    (1976)
  • P. Seeman et al.

    Nature

    (1976)
  • L.C. Iorio et al.

    J. Pharm. Exp. Ther.

    (1983)
  • G.R. Breese et al.

    Neurobiology of Central D1-Dopamine Receptors

    (1986)
  • Cited by (0)

    View full text